Alzamend Neuro ALZN
NASDAQ ALZN
$1.31 -0.04 (-2.96%)
At close: Nov 11, 2026 · 4:00 PM EST

Alzamend Neuro (ALZN) Total Non-Current Liabilities (2021 - 2026)

Updated

Alzamend Neuro (ALZN) recorded Total Non-Current Liabilities of $4.3 million in fiscal Q3 2024 (quarter ended Jan 31, 2024).

Analysis

Alzamend Neuro (ALZN) Total Non-Current Liabilities (2021 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 60.81 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 102.65 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 117.60 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 79.95 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -36.84 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 76.12 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 36.05 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 96.04 Bn
10 Alzamend Neuro 6.51 Mn -8.95 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2026 263,491.00
Apr 30, 2025 -2.04 Mn
Apr 30, 2024 586,953.00
Jan 31, 2024 4.30 Mn
Apr 30, 2023 594,013.00
Jul 31, 2022 -9.12 Mn
Jan 31, 2022 -8.36 Mn
Jul 31, 2021 -7.36 Mn
API Access

Alzamend Neuro Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ALZN&period=max&api_key=YOUR_API_KEY